| Literature DB >> 31041272 |
Monika Pathania1, Paras Malik1, Vyas Kumar Rathaur2.
Abstract
BACKGROUND: India is a tropical country with a high burden of febrile zoonotic/infectious illnesses, scrub typhus being such a cause with multiple epidemics reported from different regions of the country.Entities:
Keywords: Communicable diseases; Orientia tsutsugamushi; rickettsia; scrub typhus; zoonoses
Year: 2019 PMID: 31041272 PMCID: PMC6482722 DOI: 10.4103/jfmpc.jfmpc_124_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
A table summarising the demographic variables of the study subjects
| Variable | No. of cases | Percentage |
|---|---|---|
| Gender | ||
| Male | 14 | 25.92 |
| Female | 40 | 74.08 |
| Age (years) | ||
| <20 | 7 | 12.96 |
| 20-40 | 35 | 64.82 |
| >40 | 12 | 22.22 |
| Occupation | ||
| Housewives | 28 | 51.85 |
| Farmers | 6 | 11.11 |
| Students | 15 | 27.77 |
| Others* | 5 | 9.25 |
*Businessman, army, teacher, guard, laborer
Graph 1A graph summarising the symptoms at presentation observed in the study subjects
Graph 2A graph summarising the signs observed in the study subjects
Figure 1A figure demonstrating an eschar at abdomen
Figure 2A figure demonstrating an eschar at perineum
Graph 3A graph summarising the laboratory abnormalities observed in the study subjects
A table of comparison of clinical presentations and complications observed in our study compared to studies done in other parts of India
| Vivekanandan | Subbalaxmi | Sivarajan | Takhar | This study [Graphs | |
|---|---|---|---|---|---|
| Place; sample size | Puducherry; 50 | Andhra Pradesh; 176 | Meghalaya; 90 | Rajasthan; 66 | Uttarakhand; 54 |
| Clinical features | |||||
| Fever | 50 (100%) | 176 (100%) | 75 (83.3) | 66 (100%) | 54 (100%) |
| Myalgia | 19 (38%) | NA | 56 (62.2) | 20 (30.3%) | 40 (74.07%) |
| Altered sensorium | 10 (20%) | 23 (13.1%) | 5 (19%) | 26 (39.4%) | 14 (25.92%) |
| Headache | 20 (40%) | 92 (52.3%) | 24 (26.7) | 22 (33.3%) | 45 (83.33%) |
| Cough | 20 (40%) | 94 (53.4%) | 21 (23.3) | 32 (48.5%) | 28 (51.85%) |
| Nausea/vomiting | 29 (58%) | NA | 21 (23.3) | 18 (27.3%) | 29 (53.7%) |
| Abd. pain | 10 (20%) | NA | 24 (26.7) | NA | 39 (72.22%) |
| Loose stools | 8 (16%) | 28 (15.9%) | NA | NA | 5 (9.25%) |
| Hepatosplenomegaly | 24 (48%) | 51 (28.9%) | Hepatomegaly 24 (26.7), splenomegaly 22 (24.4) | 23 (34.8%) | Hepatomegaly 10 (18%), splenomegaly 4 (7.4%) |
| Eschar | 23 (46%) | 23 (13.1%) | 10 (11.1) | 8 (12.1%) | 7 (12.96%) |
| Upper lid edema | NA | NA | NA | NA | 40 (74.07) |
| Conjunctival congestion/hemorrhage | NA | NA | NA | NA | 3 (5.55%) |
| Complications | |||||
| Leukopenia (<4000/mm3) | 1 (2%) | 42 (23.9%) | 11 (12%) | 10 (15.1%) | 1 (1.87%) |
| Leucocytosis (>11,000/mm3) | 15 (30%) | 18 (10.2%) | 23 (25%) | 20 (30.3%) | 16 (29.62%) |
| Thrombocytopenia (<100,000/mm3) | 5 (10.8%) | 53 (30.1%) | 18 (20%) | 52 (78.8%) | 7 (12.9%) |
| Raised transaminases | 47 (95.9%) | 153 (86.9%) | ALT 85 (94%), AST 90 (100%) | 32 (48.5%) | 40 (74.07%) |
| Renal failure (criteria not defined) | 6 (12%) | 49 (27.8%) | 11 (12.2%) | 34 (51.5%) | 2 (3.70%) |
| Mortality | 1 (2%) | 8 (4.5%) | 5 (5.15%) | 21.2% | 1 (1.87%) |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NA: Data not available
A table of comparison of clinical presentations and complications observed in our study compared to studies done in other Asian countries
| Zhang et al.[ | Kun Ming Wu et al.[ | Hamaguchi et al.[ | Brummaier et al.[ | This study [Graphs | |
|---|---|---|---|---|---|
| Place; sample size | Shandong; 102 | Taiwan; 136 | Hanoi, Vietnam; 237 | North-western Thailand; 422 | Uttarakhand, India; 54 |
| Clinical features | |||||
| Fever | 102 (100%) | 134 (98.5%) | 180 (76%) | 378 (89.6%) | 54 (100%) |
| Relative bradycardia | NA | NA | 92 (39.8%) | NA | 12 (22.22%) |
| Headache | 64 (62.7%) | 85 (62.5%) | 167 (70.5%) | 224 (53.1%) | 45 (83.33%) |
| Myalgia | 48 (47.1%) | NA | 161 (67.9%) | 151 (35.8%) | 40 (74.07%) |
| Altered mental status | NA | NA | 23 (9.7%) | 7 (1.7%) | 14 (25.92%) |
| Abdt tenderness | 17 (16.7%) | 42 (30.9%) | 10 (4.3%) | 98 (23.2%%) | 29 (53.7%) |
| Nausea/vomiting | 28 (27.4%) | NA | NA | 85 (20.1%)/116 (27.5%) | 29 (53.70%) |
| Cough | 14 (13.7%) | 71 (52.5%) | 104 (43.9%) | 115 (27.3%) | 28 (51.85%) |
| Conjunctival congestion/hemorrhage | 8 (7.8%) | NA | NA | NA | 3 (5.55%) |
| Eschar | 88 (86.3%) | 82 (60.3%) | 149 (62.9%) | 38 | 7 (12.96%) |
| Rash | 70 (68.6%) | 35 (25.7%) | 74 (31.2%) | 17 (31.48%) | |
| Hepatosplenomegaly | Hepatomegaly 7 (6.9%), splenomegaly 14 (13.7%) | Hepatosplenomegaly 35 (34.7%) | Hepatosplenomegaly 118 (49.8%) | NA | Hepatomegaly 10 (18.51%), splenomegaly 4 (7.40%) |
| Upper eyelid edema | NA | NA | NA | NA | 40 (74.07%) |
| Complications | |||||
| Hepatitis | 4 (3.9%) | NA | NA | 1 (0.3%) | 4 (7.40%) |
| Bronchopneumonia | 22 (21.6%) | 13 (20.6%) | 83 (35%) | 30 (9.9%) | 1 (1.87%) |
| Pleural effusion | 1 (1%) | 27 (42.9%) | NA | NA | 1 (1.87%) |
| Renal failure | 0 | 9 (6.8%) | 19 (11.5%) | 8 (2.6%) | 2 (3.70%) |
| ARDS | NA | 4 (6.3%) | 1 (0.4%) | NA | 4 (7.4%) |
| Meningitis | 0 | NA | NA | 4 (1.3%) | 11 (20.3%) |
| Leucocytosis | 13.5% | 39 (29.8%) | 96 (40.7%) | NA | 16 (29.6%) |
| Leukopenia | 4.1% | NA | NA | NA | 1 (1.87%) |
| Thrombocytopenia | 25.4% | NA | 104 (45%) | NA | 7 (12.96%) |
| Elevated AST | 75% | NA | NA | 74 (24.4%) | 40 (74.07%) |
| Elevated ALT | 80.3% | 109/127 (85.8%) | 194 (97.5%) | 39 (72.22%) | |
| Elevated BUN | 5.7% | NA | 82 (36.4%) | 47 (87.03%) | |
| Mortality | NA | 2 (1.47%) | 1 (0.4%) | 1 (1.87%) |
NA: Data not available; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ARDS: Acute respiratory distress syndrome; BUN: Blood urea nitrogen
Figure 3A figure demonstrating sub-conjunctival haemorrhage in a study subject